[PDF] Top 20  DEVELOPMENT AND IN VITRO EVALUATION OF BUCCOADHESIVE TABLETS OF LOSARTAN POTASSIUM

... tissue. Losartan potassium is an angiotensin II receptor (type AT1) ...conventional tablets of Losartan potassium has been reported to exhibit fluctuations in the plasma drug levels, ... See full document

... A simple, specifi c, accurate, and precise reverse phase high performance liquid chromatographic method was developed and validated for the estimation of venlafaxine hydrochloride in tablet dosage forms. A Phenomenex ... See full document

... of Losartan potassium transdermal patches were done to get an idea of permeation of drug through barrier from the transdermal system 17 ...in- vitro release profile for a 10 hrs ... See full document

... matrix tablets of Losartan ...matrix tablets were developed using different drug polymer ratios and prepared by direct compression ...The tablets were evaluated for preformulation studies like ... See full document

... pump tablets of Losartan potassium to prolong the release of drug oral ...administration. Losartan potassium is an anti -hypertensive drug and it acts as an angiotension II receptor ... See full document

... by their physical parameters and in vitro dissolution profile. The sintering time markedly affected the drug release properties of Compritol® 888 ATO matrices. It is notable that the release rate of ketorolac ... See full document

... of Losartan potassium with the increase in CCS may be due to rapid swelling and disintegrating films ...of Losartan potassium can be prepared by solvent casting method with film forming ... See full document

... matrix tablets of losartan Potassium by using a combination of hydrophilic synthetic polymer like poly (ethylene oxides) and natural gums like xanthan gum, karaya gum and guar ...matrix ... See full document

... matrix tablets of losartan potassium. Tablets were prepared by direct compression and evaluated for hardness, friability, thickness, drug content and in vitro dissolution ...In ... See full document

... evaluated buccoadhesive tablets of Losartan Potassium and concluded that Hardness of the Bioadhesive tablets varied with various type and ratio of the Bioadhesive ...the tablets ... See full document

... Losartan potassium, was chosen as a drug having high solubility. Losartan potassium plays a major role in treating ...of Losartan Potassium has been formulated with greater ... See full document

... various tablets were given in (Table ...coated tablets were found to be in the range 3 ± ...coated tablets was found to be in the range ...in vitro dissolution studies using calibrated 8 ... See full document

... Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow- channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Experimental ... See full document

... Release Studies: Dissolution studies 17 were carried out for all the formulation in USP paddle method (Apparatus 2) using Phosphate buffer pH 6.8, and pH 1.2 (0.1N) HCl solution in the dissolution medium (900 ml) at 50 ... See full document

... formulated tablets were evaluated for post compression parameters (hardness, friability, weight variation, wetting time, disintegration time, water absorption ...In vitro drug release studies were carried ... See full document

... The Losartan potassium is an angiotensin-receptor blocker (ARB), is used alone or with other agents to treat ...hypertension. Losartan potassium lower blood pressure by antagonizing the ... See full document

... bilayer tablets. Tablets were prepared by direct compression technique by using mucoadhesive polymers such as Carbapol 934, HPMC and PVP in varying ...in vitro permeation studies based on its maximum ... See full document

... by development of appropriate dosage forms. Fast disintegrating tablets in mouth are best suited and have gained popularity in the oral antihypertensive drug ...compactness. Losartan potassium ... See full document

... The process of breakdown of a tablet into smaller particles is called as disintegration. The in-vitro disintegration time of a tablet was determined using disintegration test apparatus as per I.P. specifications. ... See full document

... and Losartan potassium as an immediate release bi layer tablet and to evaluate its dissolution ...formulation development work was initiated with wet granulation for losartan potassium ... See full document